| SARS-CoV-2 Omicron variant neutralization after mRNA-1273 booster vaccination R Pajon, NA Doria-Rose, X Shen, SD Schmidt, S O’Dell, C McDanal, ... New England Journal of Medicine 386 (11), 1088-1091, 2022 | 361 | 2022 |
| mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron M Gagne, JI Moliva, KE Foulds, SF Andrew, BJ Flynn, AP Werner, ... Cell 185 (9), 1556-1571. e18, 2022 | 213* | 2022 |
| mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant VV Edara, KE Manning, M Ellis, L Lai, KM Moore, SL Foster, K Floyd, ... Cell Reports Medicine 3 (2), 2022 | 196 | 2022 |
| Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant KE Lyke, RL Atmar, CD Islas, CM Posavad, D Szydlo, RP Chourdhury, ... Cell Reports Medicine 3 (7), 2022 | 132 | 2022 |
| Booster of mRNA-1273 strengthens SARS-CoV-2 Omicron neutralization NA Doria-Rose, X Shen, SD Schmidt, S O’Dell, C McDanal, W Feng, ... MedRxiv, 2021 | 87 | 2021 |
| Booster of mRNA-1273 vaccine reduces SARS-CoV-2 Omicron escape from neutralizing antibodies NA Doria-Rose, X Shen, SD Schmidt, S O’Dell, C McDanal, W Feng, ... MedRxiv, 2021 | 65 | 2021 |
| Pre-existing SARS-CoV-2 immunity influences potency, breadth, and durability of the humoral response to SARS-CoV-2 vaccination G Mantus, LE Nyhoff, VV Edara, VI Zarnitsyna, CR Ciric, MW Flowers, ... Cell Reports Medicine 3 (4), 2022 | 29 | 2022 |
| Durability of immune responses to mRNA booster vaccination against COVID-19 PS Arunachalam, L Lai, H Samaha, Y Feng, M Hu, HS Hui, B Wali, M Ellis, ... The Journal of clinical investigation 133 (10), 2023 | 26 | 2023 |
| Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough … MI Azeem, AK Nooka, U Shanmugasundaram, N Cheedarla, S Potdar, ... Blood cancer discovery 4 (2), 106-117, 2023 | 20 | 2023 |
| Antibody response to COVID-19 mRNA vaccine in patients with lung cancer after primary immunization and booster: reactivity to the SARS-CoV-2 WT virus and Omicron variant RM Valanparambil, J Carlisle, SL Linderman, A Akthar, RL Millett, L Lai, ... Journal of Clinical Oncology 40 (33), 3808, 2022 | 20 | 2022 |
| Loss of Pfizer (BNT162b2) vaccine-induced antibody responses against the SARS-CoV-2 Omicron variant in adolescents and adults SL Gupta, G Mantus, KE Manning, M Ellis, M Patel, CR Ciric, A Lu, ... Journal of virology 96 (17), e00582-22, 2022 | 16 | 2022 |
| Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: reactivity to vaccine antigen and variants of concern RM Valanparambil, J Carlisle, SL Linderman, A Akthar, RL Millett, L Lai, ... MedRxiv, 2022.01. 03.22268599, 2022 | 15 | 2022 |
| Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies A Chang, JL Koff, L Lai, VM Orellana-Noia, M Surati, AMK Leal, ML Ellis, ... Blood advances 7 (11), 2459-2462, 2023 | 8 | 2023 |
| Mucosal adenoviral-vectored vaccine boosting durably prevents XBB. 1.16 Infection in nonhuman primates M Gagne, BJ Flynn, SF Andrew, DR Flebbe, A Mychalowych, E Lamb, ... bioRxiv, 2023.11. 06.565765, 2023 | 4 | 2023 |
| XBB. 1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variants S Jain, S Kumar, L Lai, S Linderman, AA Malik, ML Ellis, S Godbole, ... bioRxiv, 2024.02. 03.578771, 2024 | 1 | 2024 |
| Patients on Benralizumab, Dupilumab, or Mepolizumab Have Lower Post-vaccination SARS-CoV-2 Immunity P Lamothe, M Runnstrom, C Faliti, N Cheedarla, A Moreno, M Suthar, ... C101. UNDERSTANDING LUNG IMMUNITY IN THE BATTLE AGAINST INFECTION, A6694-A6694, 2024 | | 2024 |
| A Real Catastrophe: Think Beyond, Think Fast ML Ellis, S Kumar, O Elkadi, BW Fouty C104. BLEEDING AND CLOTTING AND EMBOLI, OH MY! HEMATOLOGIC CASES IN THE ICU …, 2024 | | 2024 |
| AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans L Grigoryan, Y Feng, L Bellusci, L Lai, B Wali, M Ellis, M Yuan, ... Science Immunology 9 (94), eadi8039, 2024 | | 2024 |
| Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera B Mühlemann, SH Wilks, L Baracco, M Bekliz, JM Carreño, VM Corman, ... bioRxiv, 2023 | | 2023 |
| Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity A Moreno, K Manning, MI Azeem, AK Nooka, M Ellis, RJ Manalo, ... Research Square, 2023 | | 2023 |
